Simple and scalable method for peptide inhalable powder production

European Journal of Pharmaceutical Sciences

Volumn 39, Issue 1-3, 2010, Pages 53-58

  Schoubben, Aurélie ^a   Blasi, Paolo ^a   Giovagnoli, Stefano ^a   Ricci, Maurizio ^a   Rossi, Carlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Capreomycin sulfate; Hydrophobic ion pair; PLGA microparticles; Respirable powder; Sodium oleate; Spray drying

Indexed keywords

CAPREOMYCIN; OLEATE SODIUM; POLYGLACTIN; POLYMER;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; HYDROPHOBICITY; ION PAIR EXTRACTION; MICROENCAPSULATION; MORPHOLOGY; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; POWDER INHALER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPECTROPHOTOMETRY; SPRAY DRYING;

ADMINISTRATION, INHALATION; ANTIBIOTICS, ANTITUBERCULAR; BIOCOMPATIBLE MATERIALS; CALORIMETRY, DIFFERENTIAL SCANNING; CAPREOMYCIN; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; OLEIC ACID; PARTICLE SIZE; PEPTIDES; POLYGLYCOLIC ACID; POWDERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 73749084878     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.10.010     Document Type: Article

References (35)

1. Blasi P., Schoubben A., Giovagnoli S., Rossi C., and Ricci M. Fighting tuberculosis: old drugs, new formulations. Expert Opin. Drug Deliv. 6 (2009) 977-993
2. Brain J.D., and Valberg P.A. Deposition of aerosols in the respiratory tract (review). Am. Rev. Respir. Dis. 120 (1979) 1325-1373
3. Byron P.R., and Patton J.S. Drug delivery via the respiratory tract. J. Aerosol Med. 7 (1994) 49-75
4. Choi S.H., and Park T.G. Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres. Int. J. Pharm. 203 (2000) 193-202
5. DeLuca P.P., Mehta R.C., Hausberger A.G., and Thanoo B.C. Biodegradable polyesters for drug and polypeptide delivery. In: El-Nokaly M.A., Piatt D.M., and Charpentier B.A. (Eds). Polymeric Drug Delivery Systems (1993), American Chemical Society, Washington, DC 53-79
6. Edge S., Mueller S., Price R., and Shur J. Factors affecting defining the quality and functionality of excipients used in the manufacture of dry powder inhaler products. Drug Dev. Ind. Pharm. 34 (2008) 966-973
7. Edwards D.A., Hanes J., Caponetti G., Hrkach J., Ben-Jebria A., Eskew M.L., Mintzes J., Deaver D., Lotan N., and Langer R. Large porous particles for pulmonary drug delivery. Science 276 (1997) 1868-1871
8. Fattorini L., Iona E., Ricci M.L., Thoresen O.F., Orru G., Oggioni M.R., Tortoli E., Piersimoni C., Chiaradonna P., Tronci M., Pozzi G., and Orefici G. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Microb. Drug Resist. 5 (1999) 265-270
9. Fong J.W., Nazareno J.P., Pearson J.E., and Maulding H.V. Evaluation of biodegradable microspheres prepared by a solvent evaporation process using sodium oleate as emulsifier. J. Control. Release 3 (1986) 119-130
10. Frazza E.J., and Schmitt E.E. A new absorbable suture. Biomed. Mater. Res. 5 (1971) 43-58
11. Giovagnoli S., Blasi P., Schoubben A., Rossi C., and Ricci M. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Int. J. Pharm. 333 (2007) 103-111
12. Goula A.M., and Adamopoulos K.G. Spray drying of tomato pulp: effect of feed concentration. Drying Technol. 22 (2004) 2309-2330
13. Gursoy A. Liposome-encapsulated antibiotics: physicochemical and antibacterial properties, a review. STP Pharma Sci. 10 (2000) 285-291
14. Jain R., Shah N.H., Malick A.W., and Rhodes C.T. Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Dev. Ind. Pharm. 24 (1998) 703-727
15. Jiang G., Qui W., and De Luca P.P. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl hydroxyethyl starch)-PLGA composite microspheres. Pharm. Res. 20 (2003) 452-459
16. Lu D., Garcia-Contreras L., Xu D., Kurtz S.L., Liu J., Braunstein M., McMurray D.N., and Hickey A.J. Poly(lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B. Pharm. Res. 24 (2007) 1834-1843
17. Newhouse M.T. Hemoptysis due to MDI therapy in a patient with permanent tracheostomy. Chest 115 (1999) 279-282
18. Okada H., Doken Y., Ogawa Y., and Toguchi H. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res. 11 (1994) 1143-1147
19. Rossi C., Fardella G., Chiappini I., Perioli L., Vescovi C., Ricci M., Giovagnoli S., and Scuota S. UV spectroscopy and reverse-phase HPLC as novel methods to determine capreomycin of liposomal formulations. J. Pharm. Biomed. Anal. 36 (2004) 249-255
20. Ruffin R.E., Campbell D.A., and Chia M.M. Post-inhalation bronchoconstriction by beclomethasone dipropionate: a comparison of two different CFC propellant formulations in asthmatics. Respirology 5 (2000) 125-131
21. Schlesinger R.B. Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J. Toxicol. Environ. Health 15 (1985) 197-214
22. Sharma R., Saxena D., Dwivedi A.K., and Misra A. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm. Res. 18 (2001) 1405-1410
23. Sivadas N., O'Rourke D., Tobin A., Buckley V., Ramtoola Z., Kelly J.G., Hickey A.J., and Cryan S.A. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int. J. Pharm. 358 (2008) 159-167
24. Steckel H., and Brandes H.G. A novel spray-drying technique to produce low density particles for pulmonary delivery. Int. J. Pharm. 278 (2004) 187-195
25. Tandon P., Raudenkolb S., Neubert R.H.H., Rettig W., and Wartewig S. X-ray diffraction and spectroscopic studies of oleic acid-sodium oleate. Chem. Phys. Lipids 109 (2001) 37-45
26. Tandon P., Neubert R., and Wartewig S. Thermotropic phase behaviour of sodium oleate as studied by FT-Raman spectroscopy and X-ray diffraction. J. Mol. Struct. 526 (2000) 49-57
27. Tomoda K., Kojima S., Kajimoto M., Watanabe D., Nakajima T., and Makino K. Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres. Colloids Surf. B: Biointerfaces 45 (2005) 1-6
28. Ungaro F., De Rosa G., Miro A., Quaglia F., and La Rotonda M.I. Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs. Eur. J. Pharm. Sci. 28 (2006) 423-432
29. van de Weert M., Hering J.A., and Haris P.I. Fourier transform infrared spectroscopy. In: Jiskoot W., and Crommelin D. (Eds). Methods for Structural Analysis of Protein Pharmaceuticals (2005), AAPS Press, Arlington 131-166
30. Vehring R. Pharmaceutical particle engineering via spray drying. Pharm. Res. 25 (2008) 999-1022
31. Vold R.D. Phase boundaries in concentrated systems of sodium oleate and water. J. Phys. Chem. 51 (1947) 797-816
32. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emerg. Update (2008)
33. Yeo Y., and Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch. Pharm. Res. 27 (2004) 1-12
34. Zainudin B.M. Therapeutic aerosol: principles and practices. Med. J. Malaysia 48 (1993) 259-268
35. Zhou H., Zhang Y., Biggs D.L., Manning M.C., Randolph T.W., Christians U., Hybertson B.M., and Ng K.Y. Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages. J. Control. Release 107 (2005) 288-299